Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
ImClone Systems Incorporated - SWOT Analysis (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 16/05/2008
- Report Title: ImClone Systems Incorporated - SWOT Analysis
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 28
ImClone Systems Incorporated - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
ImClone Systems (ImClone) is a biopharmaceutical company specializing in the development of therapeutic products for the treatment of cancer and cancer-related disorders, as well as diagnostic products and vaccines for a number of infectious diseases. ImClone is headquartered in New York City, New York and employs about 1,000 people. The company recorded revenues of $590.8 million during the fiscal year ended December 2007, a decrease of 12.8% over 2006. The operating profit of the company was $51.5 million during fiscal year 2007, compared to an operating profit of $289.2 million in 2006. The net profit in fiscal year 2007 was $39.8 million, compared to a net profit of $370.7 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
ImClone Systems (ImClone) is a biopharmaceutical company specializing in the development of therapeutic products for the treatment of cancer and cancer-related disorders, as well as diagnostic products and vaccines for a number of infectious diseases. ImClone is headquartered in New York City, New York and employs about 1,000 people. The company recorded revenues of $590.8 million during the fiscal year ended December 2007, a decrease of 12.8% over 2006. The operating profit of the company was $51.5 million during fiscal year 2007, compared to an operating profit of $289.2 million in 2006. The net profit in fiscal year 2007 was $39.8 million, compared to a net profit of $370.7 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
